A 59-Year-Old Woman With HER2+ De Novo Metastatic Breast Cancer

A 59-Year-Old Woman With HER2+ De Novo Metastatic Breast Cancer

EP. 1: HER2+ De Novo Metastatic Breast Cancer Case Report

April 16th 2020

EP. 2: Recommendations for HER2 Testing in Metastatic Breast Cancer

April 16th 2020

EP. 3: Early Lines of Therapy for HER2+ De Novo Metastatic Breast Cancer

April 16th 2020

EP. 4: Selecting Third-Line Therapy to Treat HER2+ De Novo Metastatic Breast Cancer

April 16th 2020

EP. 5: HER2+ De Novo MBC: Neratinib Vs Lapatinib Plus Capecitabine

April 16th 2020

EP. 6: Neratinib Prophylaxis in HER2+ Metastatic Breast Cancer

April 16th 2020

Advertisement

Advertisement